GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Black Bird Biotech Inc (OTCPK:BBBT) » Definitions » Gross Profit

Black Bird Biotech (Black Bird Biotech) Gross Profit : $0.01 Mil (TTM As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Black Bird Biotech Gross Profit?

Black Bird Biotech's gross profit for the three months ended in Sep. 2023 was $0.00 Mil. Black Bird Biotech's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was $0.01 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Black Bird Biotech's gross profit for the three months ended in Sep. 2023 was $0.00 Mil. Black Bird Biotech's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Black Bird Biotech's Gross Margin % for the quarter that ended in Sep. 2023 was 25.00%.

Black Bird Biotech had a gross margin of 25.00% for the quarter that ended in Sep. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Black Bird Biotech was 50.00%. The lowest was 19.23%. And the median was 39.76%.


Black Bird Biotech Gross Profit Historical Data

The historical data trend for Black Bird Biotech's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Black Bird Biotech Gross Profit Chart

Black Bird Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.03 0.02 0.03

Black Bird Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - 0.01 -

Competitive Comparison of Black Bird Biotech's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Black Bird Biotech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Black Bird Biotech's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Black Bird Biotech's Gross Profit distribution charts can be found below:

* The bar in red indicates where Black Bird Biotech's Gross Profit falls into.



Black Bird Biotech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Black Bird Biotech's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=0.083 - 0.05
=0.03

Black Bird Biotech's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=0.004 - 0.003
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Black Bird Biotech's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0.004
=25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Black Bird Biotech  (OTCPK:BBBT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Black Bird Biotech had a gross margin of 25.00% for the quarter that ended in Sep. 2023 => Competition eroding margins


Black Bird Biotech Gross Profit Related Terms

Thank you for viewing the detailed overview of Black Bird Biotech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Black Bird Biotech (Black Bird Biotech) Business Description

Traded in Other Exchanges
N/A
Address
11961 Hilltop Road, Suite 22, Argyle, TX, USA, 76226
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.
Executives
Jeffrey A Collins director, 10 percent owner, officer: President 302 WASHINGTON ST., #513, SAN DIEGO CA 92103
Robert Edward Shea director, 10 percent owner, officer: President, CEO, CFO, CAO 40 WARREN STREET, 3RD FLOOR, CHARLESTOWN MA 02129
John James Sutherland director, 10 percent owner, officer: President, CEO, CFO & CAO C/O SUITE 810 - 675 WEST HASTINGS STREET, VANCOUVER A1 V6B 1N2

Black Bird Biotech (Black Bird Biotech) Headlines

From GuruFocus